Urinary Pain (Dysuria) — Causes, UTI Treatment & Prevention — Causes, Diagnosis & When to See a Doctor | MyMedicPlus

Urinary pain (dysuria) describes pain, burning, stinging, or discomfort experienced during or after urination, often accompanied by urinary frequency (needing to pass urine more often), urgency (sudden compelling need to urinate), and sometimes haematuria (blood in the urine). It is one of the most common urological complaints encountered in both primary care and emergency settings. Approximately 50% of women will experience at least one urinary tract infection (UTI) during their lifetime, and approximately 25-30% will suffer recurrent infections (three or more per year). The markedly higher UTI incidence in women compared to men — approximately 30-fold higher lifetime risk — reflects the anatomical difference in urethral length: the female urethra is approximately four centimetres long compared to approximately twenty centimetres in men, providing a substantially shorter distance for ascending bacteria to reach the bladder from the perineal flora. UTIs range from uncomplicated lower UTIs (cystitis) confined to the bladder and urethra in otherwise healthy, non-pregnant, non-catheterised women, to complicated upper UTIs (pyelonephritis — kidney infection) in which bacteria ascend to one or both kidneys, causing systemic infection and risk of sepsis. Dysuria can also result from non-infectious causes including urological stones, interstitial cystitis, sexually transmitted infections, postmenopausal atrophy, and bladder malignancy — a broader differential to consider particularly when standard antibiotics fail to resolve symptoms.

The most common cause by far is bacterial urinary tract infection — Escherichia coli accounts for 80-85% of all uncomplicated UTIs in both community and healthcare settings. Other uropathogens include Klebsiella pneumoniae, Staphylococcus saprophyticus (common in sexually active young women), Proteus mirabilis, and Enterococcus faecalis. In men and in sexually active individuals of either sex, sexually transmitted infections are an important and frequently missed cause of dysuria and urethritis: Chlamydia trachomatis (the most common bacterial STI globally — often asymptomatic in women), Neisseria gonorrhoeae (causing thick purulent urethral discharge and dysuria — increasing antibiotic resistance is a major concern), Trichomonas vaginalis, Mycoplasma genitalium, and herpes simplex virus (causing extremely painful dysuria with visible genital ulceration). Kidney stones (nephrolithiasis) cause intermittent, colicky, severe flank-to-groin pain with haematuria — the stone causes dysuria when it reaches the ureterovesical junction or urethra. Interstitial cystitis (IC)/bladder pain syndrome is a chronic condition causing suprapubic pain, urinary frequency and urgency, and dysuria without any bacterial infection — a diagnosis of exclusion. Vaginal atrophy from oestrogen deficiency in postmenopausal women causes dysuria and increased UTI susceptibility due to reduced protective Lactobacillus colonisation. Prostatitis (acute bacterial prostatitis from E. coli or other gram-negatives) causes dysuria, perineal pain, obstructive symptoms, and fever in men. Bladder cancer — particularly transitional cell carcinoma — can present with painless haematuria and dysuria, particularly in older male smokers.

Seek urgent medical assessment the same day for dysuria accompanied by fever above 38°C, rigors (uncontrollable shaking chills), and loin, flank, or back pain — this constellation is the classic presentation of pyelonephritis (kidney infection), which requires prompt antibiotic treatment to prevent bacteraemia, sepsis, and acute kidney injury. Nausea, vomiting, and inability to maintain oral antibiotic therapy with pyelonephritis warrants hospital admission for intravenous antibiotics and fluids. Seek emergency assessment for dysuria in a person who is clearly systemically unwell with hypotension, confusion, or extreme tachycardia — this suggests urosepsis, which carries a mortality of 20-40% without early aggressive treatment including intravenous antibiotics within one hour and fluid resuscitation. Also seek urgent assessment for complete inability to urinate (acute urinary retention) — this is a urological emergency, particularly common in men with benign prostatic hyperplasia or urethral stricture, requiring urgent catheterisation to prevent bladder damage and renal injury. Seek prompt assessment for frank visible blood in the urine (haematuria) accompanying dysuria — while often from infection, painless haematuria in anyone over 50 requires urgent urology referral to exclude bladder cancer. All pregnant women with dysuria require prompt same-day assessment and treatment, as UTIs in pregnancy significantly increase the risk of pyelonephritis, preterm labour, and low birth weight.

Urinalysis using a dipstick test detects leucocyte esterase (indicating white blood cells — pyuria, the hallmark of infection), nitrites (produced by gram-negative bacteria including E. coli by reducing urinary nitrates — specific but not sensitive), blood (haematuria), protein, and glucose. A positive leucocyte esterase plus nitrites has a positive predictive value over 90% for bacterial UTI and is sufficient to guide empirical antibiotic treatment in a typical uncomplicated cystitis presentation. Urine microscopy visualises white and red blood cells and casts. Urine culture and antimicrobial sensitivity testing (MCUS) identifies the causative organism and guides antibiotic selection — essential for recurrent, complicated, or treatment-resistant UTIs, and recommended for all men, pregnant women, and catheterised patients with UTI. Nucleic acid amplification testing (NAAT) — urethral, vaginal, or urine swabs — detects Chlamydia trachomatis and Neisseria gonorrhoeae with near 100% sensitivity and is the gold standard STI diagnostic test. In men, PSA measurement and digital rectal examination are performed when prostatitis is suspected in those over 50 years. Renal and bladder ultrasound or non-contrast CT kidney-ureter-bladder (KUB) identifies urinary tract stones, hydronephrosis (from ureteric obstruction), and bladder abnormalities including masses. Cystoscopy is the definitive investigation for bladder cancer and interstitial cystitis.

Uncomplicated lower UTI (cystitis) in non-pregnant, otherwise healthy women is treated with a three to five day course of oral antibiotics — first-line choices are nitrofurantoin (five to seven days — avoid if eGFR below 45), trimethoprim (three days — check local resistance rates, as high trimethoprim resistance in some regions limits its use), or pivmecillinam (three to seven days) according to local antibiotic stewardship guidelines and known allergy history. Symptom relief typically occurs within 24-48 hours of starting effective antibiotics. Phenazopyridine or urinary alkalinisation (sodium bicarbonate sachets) provides symptomatic relief of burning and dysuria while awaiting antibiotic effect — these are treatments for symptoms only, not the infection. Increase fluid intake to at least two litres per day to promote urinary flushing and bacterial clearance. Pyelonephritis (kidney infection) requires a longer antibiotic course — seven to fourteen days — and hospitalisation for intravenous antibiotics (ceftriaxone or gentamicin) is required for severe illness, inability to take oral medication, pregnancy, or significant immunosuppression. STI-related urethritis from chlamydia is treated with a single dose of azithromycin one gram, or doxycycline 100 mg twice daily for seven days; gonorrhoea requires ceftriaxone 1g intramuscularly plus azithromycin due to rising resistance; partner notification and testing is mandatory. Interstitial cystitis is managed with bladder retraining, dietary modification (reducing bladder irritants — caffeine, alcohol, citrus, spicy foods), pelvic floor physiotherapy, bladder instillations, and specialist urology input. Recurrent UTIs (three or more per year) may benefit from low-dose continuous prophylactic antibiotics, post-coital single-dose prophylaxis, or self-initiated treatment protocols.

Maintain adequate daily fluid intake — at least 1.5 to 2 litres of water per day — to produce dilute urine and promote regular bladder flushing, reducing bacterial concentration and colonisation time. Urinate promptly when the urge arises and fully empty the bladder — avoid prolonged urine retention, which allows bacteria time to multiply. After bowel movements, wipe from front to back to prevent faecal bacteria from the rectum (including E. coli) contaminating the periurethral area. Urinate before and immediately after sexual intercourse — post-coital voiding reduces bacterial inoculation of the urethra and is one of the most effective behavioural UTI prevention strategies, reducing post-coital UTI incidence by 50-80% in susceptible women. Avoid using harsh soaps, vaginal douches, perfumed products, and bubble baths in the genital area — these disrupt the protective Lactobacillus flora and alter vaginal pH, increasing susceptibility to both UTI and vaginal infections. Wear breathable cotton underwear rather than synthetic fabrics. For postmenopausal women, vaginal oestrogen cream (topical, not systemic) restores Lactobacillus colonisation and dramatically reduces recurrent UTI frequency — it is safe and highly effective. Cranberry products (juice or supplement capsules) modestly reduce recurrent UTI risk in susceptible women through anti-adhesion mechanisms (proanthocyanidins prevent E. coli fimbriae adhering to uroepithelium), though evidence is inconsistent. D-mannose (a natural sugar — 2 g daily) has stronger evidence for preventing recurrent E. coli UTIs and is an effective non-antibiotic option.

Seek emergency care immediately for dysuria with fever, rigors, and loin or back pain in someone who appears systemically very unwell — urosepsis is a life-threatening emergency requiring urgent intravenous antibiotics within one hour of triage. Call emergency services. Also go to an emergency department for acute inability to urinate (urinary retention) — this is a urological emergency. Seek urgent same-day medical assessment for dysuria with fever above 38°C and back or flank pain (possible pyelonephritis — requires prompt antibiotic therapy to prevent sepsis), dysuria in a pregnant woman (any UTI in pregnancy is treated as potentially complicated and requires immediate same-day assessment and treatment to prevent premature labour), visible blood in urine, or dysuria in an immunocompromised patient or diabetic (higher risk of serious infection). Arrange an urgent next-day appointment for dysuria with urethral discharge in either sex (STI screening required), dysuria in a male patient (UTIs in men are considered complicated and require investigation for structural abnormality), or failure of symptoms to improve within 48 hours of starting antibiotics (possible resistance — urine culture result needed). Seek a routine appointment for recurrent UTIs (three or more per year) — a review of prevention strategies, investigation for anatomical abnormality or risk factors, and consideration of prophylactic antibiotics or non-antibiotic alternatives is warranted. Any haematuria in a person over 50 years without clearly confirmed UTI requires urgent urology referral to exclude bladder malignancy, even after symptoms resolve.